New Drugs Seminars: New Drugs Mini-Conference

Event Date 6 September 2016
Lecture Theatre 2
Grimond Building
University of Kent
Canterbury, CT2 7NZ

University of Kent presents:

New Drug Seminars

Concluding Conference: New Drugs Mini-Conference

On Tuesday 6th September, we will come together for the final event in our ESRC new drugs seminar series which will be held at the University of Kent in Grimmond Lecture Theatre 2.

The aims of the day are:

(i) to consolidate what we have learnt from previous seminars

(ii) to showcase work from our special issue in the International Journal of Drug Policy

(ii) to connect with a wider audience

(iv) to consider the intersections between new drug research and research on existing drug use, drug cultures, drug markets, drug interventions, drug policy etc.

Programme:

What have we learnt so far?  Introduction to the day (Dr Caroline Chatwin, University of Kent)

Play

————————————————————-

Performance and Image Enhancing Drugs: spotlight on steroids

Ask Vest Christiansen (Aarhus University, Denmark) – Outline of a typology of anabolic androgenic steroid use in gyms and fitness environments

Talk:

Play

Questions:

Play

accompanying images:

————————————————————-

Gisella Hanley-Santos (Plymouth University) – Examining the motivations, practices and accounts of users of steroids and other performance and image enhancing drugs

Talk:

Play

Questions:

Play

accompanying images:

————————————————————-

Alexandra Hall and Georgios Antonopoulos (Teeside University) – Illicit supply and consumer demand of steroids in the UK

Talk:

Play

Questions:

Play

————————————————————-

Roundtable: New drugs and the ‘bigger picture’

A collection of eminent drug researchers consider the impact that new drugs have had on the work that they do, for example in reconstituting the way that we think about legislating for the control of drugs, designing interventions to help people who use drugs, and understanding the way that drugs are bought and sold.

Participants include Professor Susanne McGregor (London School of Hygiene and Tropical Medicine), Professor Dave Boothroyd (University of Lincoln), Professor Shane Blackman (Canterbury Christchurch University), Professor Alex Stevens (University of Kent) and Dr. Axel Klein (Global Drug Policy Observatory, Swansea University).

Play

—————————————————————-

New Psychoactive Substances

Mireia Ventura and Pol Quintana (Energy Control, Barcelona) – The deep web and the fentanyl problem: detection of ocfentanil as an adulterant in heroin

Talk:

Play

Questions:

Play

accompanying images:

————————————————————-

Bryce Pardo (University of Maryland, USA) – New Psychoactive Substances: Is a regulated legal market feasible?

Talk:

Play

Questions:

Play

accompanying images:

————————————————————-

Rob Ralphs (Manchester Metropolitan University) – Adding Spice to the Porridge: the development of a synthetic cannabinoid market in an English prison

Talk:

Play

Questions:

Play

accompanying images:

—————————————————————–

Roundtable: Where next for new drugs research?

A collection of key stakeholders in the new drugs debate consider what research is needed in order to further understand this complex field.

Participants include Rick Bradley (Addaction), Charlotte Davies (freelance drug policy consultant), Professor Harry Sumnall (Liverpool John Moores University), Josie Smith (Public Health Wales), and Martin Chandler (freelance human enhancement drugs researcher).

Play
share this entry: